Edesa Biotech Q2 EPS Forecast Boosted by Zacks Small Cap
Edesa Biotech, Inc. (NASDAQ:EDSA – Free Report) – Research analysts at Zacks Small Cap raised their Q2 2025 EPS estimates for Edesa Biotech in a note issued to investors on Monday, March 3rd. Zacks Small Cap analyst D. Bautz now forecasts that the company will post earnings of ($0.17) per share for the quarter, up […]
